EGFP (200-208)
Cat.No:CLP0587 Solarbio
CAS:323198-39-6
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My CartCAS:323198-39-6
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
CAS | 323198-39-6 |
Sequence(1LC) | HYLSTQSAL |
Sequence(3LC) | His-Tyr-Leu-Ser-Thr-Gln-Ser-Ala-Leu |
Molecular Formula | C45H70N12O15 |
Molecular Weight | 1019.12 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Solubility | DMSO:≥45 mg/mL; *Ultrasonic solubilization; |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | Other Peptides |
Background | This peptide is H2-Kd-restricted enhanced green fluorescent protein (EGFP)-derived peptide (200-208) and represents a CD8 T cell epitope. Immunization with this peptide stimulates IFNg production, thus making this peptide a model tumor antigen for the experimental development of antigen-specific vaccines against cancer. |
In Vitro | undetected |
Reference | [1] Wysocki, P. et al. Clin Cancer Res 12, 4095 (2006); [2] Sharma, S. et al. J Immunol 177, 8348 (2006); [3] Wingender, G. et al. Eur J Immunol 36, 12 (2006); [4] Gambotto, A. et al. Gene Ther 7, 2036 (2000). |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.